“…It is challenging to achieve an optimal balance between in vivo stability and ADV threshold due to the discrepancy of high stability and low ADV threshold, as well as the complex effects of various parameters, such as nanodroplet properties (e.g., PFC core species, shell composition and droplet size), acoustic parameters (e.g., ultrasound frequency and pulse duration), medium rheology and ambient pressure/temperature, etc. [15] , [16] , [17] , [18] , [19] . One attempt has been made to reduce the ADV threshold via utilizing PFC species with lower boiling points (e.g., perfluoropropane or perfluorobutane) [20] , [21] , but these PFCs are more water soluble [22] , faster clear and more likely to occur spontaneous vaporization during in vivo circulation [1] , [2] , [3] , [4] , which would limit their utility.…”